Mesai Biotech
Hangzhou
About Mesai Biotech
Mesai Biotech produces a range of tumor immunotherapy drugs to provide new therapies. In addition, they offer technical services that include recombinant protein customization, monoclonal antibody drug screening, structural biology, antibody engineering, antibody epitope determination, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $21.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2026)
- Website: medimscience.com
- Phone: (0571) 8210 1560
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/mesai-biotech-2620089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.